Shivinder Singh (left) and Malvinder Singh, former promoters of Fortis Healthcare
has ordered these 10 entities, which includes Religare Finvest and Fortis Hospitals, not to dispose of any of their assets without the prior permission of Sebi.
Also, the Singh brothers, founders of Fortis Healthcare, have been directed not to associate themselves with the affairs the company in any manner.
The matter pertains to alleged diversion of funds to promoters and misrepresentation of financial statements at Fortis Healthcare.
took note of a news
article, dated Februry 9, 2019, which stated promoters of Fortis Healthcare
had taken at least Rs 5 billion out of the company. The article also stated that auditors Deloitte Haskins & Sells had refused to sign off on the company’s second-quarter results for FY 2017-18, until the funds were accounted for or returned.
Subsequently, Sebi meet with the auditors to understand the issues raised in the news
article. Based on the discussion with the auditors, Sebi found that Fortis Healthcare, through its subsidiary, was giving inter corporate deposits (ICDs) to three companies
to the tune of Rs 4.73 billion from 2013-14 onwards. These transactions were not classified as related party transactions.
These loans were given in the beginning of each quarter and returned by the companies
by the end of the quarter and thereby never reported in the balance sheet as the outstanding amount at the end of the quarter was nil, says the Sebi order. However, for the quarter ended September 2017, the amount was not returned by the borrowers. On independent examination of filings of these borrowers, it came to light that they did not have enough cash flows to repay the amount to Fortis Healthcare, said Sebi. Also, these three companies
had the same set of directors. Based on the discussions with the auditors, Sebi conducted a preliminary examination into the matter.
The investigations found that the ultimate beneficiaries of the fund diversion prima facie were Shivinder and Malvinder Singh.
During 2017-18, Fortis Healthcare made a provision for Rs 4.45 billion “exceptional loss” on account of loans extended to three borrowers. However, Sebi found that prima facie the loss was entirely due to diversion of funds to promoters and promoter related entities. In the order, Sebi has said a detailed investigation to find out the role of each entity in the alleged routing of funds will be carried out. The regulator has also said the investigation will be extended to any entity, including banks and auditors, who could have played a role, directly or indirectly in the entire fraud.
“However, pending a detailed investigation into the entire fraud involving diversion of funds from Fortis Healthcare to its promoters and promoter-related entities, an urgent need is felt to pass an ad-interim ex-parte order to protect the interests of shareholders of Fortis Healthcare and to prevent any further deterioration of funds or assets,” said Sebi in an order.